Profil

CHEVIGNÉ Andy

University of Luxembourg

Main Referenced Co-authors
KRÜGER, Rejko  (2)
Meyrath, Max (2)
Benkel, Tobias (1)
Domingues, Olivia (1)
Kostenis, Evi (1)
Main Referenced Keywords
ACKR3 (1); Angiotensin-Converting Enzyme 2 (1); Antibodies, Neutralizing (1); Antibodies, Viral (1); Cell Fusion (1);
Main Referenced Disciplines
Neurology (1)
Biochemistry, biophysics & molecular biology (1)

Publications (total 2)

The most downloaded
108 downloads
Meyrath, M., SZPAKOWSKA, M., Plesseria, J.-M., Domingues, O., Langlet, J., Weber, B., KRÜGER, R., OLLERT, M., & CHEVIGNÉ, A. (09 September 2022). Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Methods in Enzymology, 675, 351-381. doi:10.1016/bs.mie.2022.07.015 https://hdl.handle.net/10993/54409

The most cited

105 citations (OpenAlex)

Meyrath, M., Szpakowska, M., Zeiner, J., Massotte, L., Merz, M. P., Benkel, T., Simon, K., OHNMACHT, J., TURNER, J., KRÜGER, R., Seutin, V., Ollert, M., Kostenis, E., & CHEVIGNÉ, A. (2020). The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Nature Communications, 11 (1), 3033. doi:10.1038/s41467-020-16664-0 https://hdl.handle.net/10993/43590

Meyrath, M., SZPAKOWSKA, M., Plesseria, J.-M., Domingues, O., Langlet, J., Weber, B., KRÜGER, R., OLLERT, M., & CHEVIGNÉ, A. (09 September 2022). Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Methods in Enzymology, 675, 351-381. doi:10.1016/bs.mie.2022.07.015
Peer Reviewed verified by ORBi

Meyrath, M., Szpakowska, M., Zeiner, J., Massotte, L., Merz, M. P., Benkel, T., Simon, K., OHNMACHT, J., TURNER, J., KRÜGER, R., Seutin, V., Ollert, M., Kostenis, E., & CHEVIGNÉ, A. (2020). The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Nature Communications, 11 (1), 3033. doi:10.1038/s41467-020-16664-0
Peer Reviewed verified by ORBi

Contact ORBilu